Pharmacy researchers develop nanoparticle-based treatment for glioblastoma

A team of researchers, including members from the University of Connecticut, has developed a nanoparticle-based treatment that targets multiple culprits in glioblastoma, a particularly aggressive and deadly form of brain cancer.